REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
16/03/2026
Voltar para busca
Dado oficial do USPTO
GENETYPE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
45
Atualização mais recente
17/03/2026
Tipo de marca
Mista
Classes Nice
1, 5, 9, 42, 44
Data de depósito
06/03/2019
Data de registro
16/03/2021
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/03/2021
Última transação
17/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
98
Localização do titular
AU
Examinador
MAHONEY, PAULA M
Unidade examinadora
N10
Localização atual
TMO LAW OFFICE 119
Descrição da marca
The mark consists of the stylized wording "GENETYPE" to the right of a stylized design of an oblong shape, similar to the numeral "8". There is a single dot above and to the right of the oblong shape.
Titulares e representantes
Titulares
RHY Genetype Pty Ltd
Genetic Technologies Limited
Representantes
Charles G. Zug Nelson Mullins Riley & Scarborough LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Diagnostic preparations and reagents for scientific use; diagnostic preparations and reagents for scientific laboratory use; diagnostic test kits comprised primarily of reagents and assays for scientific use
Classe 5
Pharmaceutical and veterinary preparations for the treatment of a wide variety of diseasesdiagnostic kits consisting primarily of primersprobesbuffersreagents for use in genetic testing for medical purposes; diagnostic preparations and reagents for medical use; diagnostic test kits comprised primarily of reagents and assays for medical use
Classe 9
Apparatus and instrumentsDNA genotyping arraysDNA sequencing instrumentscomputer hardwarerecorded computer programsdownloadable software all featuring proprietary algorithms to analyse DNA; scientific and teaching apparatus and instrumentsdownloadable electronic publications in the nature of bookspamphletsbrochuresnewslettersjournalsmagazines and periodicals in the field of risk assessment testing; recorded computer software and downloadable computer software to analyse and record the results of DNA testing; equipment to analyse and record the results of DNA testinglaboratory devices for detecting genetic and protein substancesDNA genotyping arraysDNA sequencing instrumentsrecorded software for scientific analysis of genetic and protein sequencesassessment kits comprised primarily of laboratory swabs and also containing bar-coded specimen envelopeinstruction sheetspecimen information formpre-paid mailing envelope
Classe 42
Biotechnology research and development services for othersincluding genetic association studiesgenome mappinggenome analysis and genome scanningpharmaceutical drug and therapeutics development; product developmentincluding consumer health product development and consultation in the field of genomics and pharmaceutical drug development; provision of scientific and medical research in the fields of DNA typing and profiling; computer programming services for DNA typing and profiling for use in medical research * ; genetic testing for medical purposes and forensic biological screening of DNA for medical purposes *
Classe 44
Medical diagnostic servicesreagent sample testing and diagnostic services for others in the fields of science and medical research; genetic testing for medical purposesgenome mappinggenome analysisgenome scanning; provision of medical servicesveterinary servicesgenetic testing for medical purposes and forensic biological screening of DNA for medical purposes ; providing medical diagnostic services and veterinary diagnostic services
Publicações
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
CHLD
CHANGE OF OWNER RECEIVED FROM IB
21/02/2025
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
26/04/2022
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
12/12/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/07/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
16/06/2021
FIMP
FINAL DISPOSITION PROCESSED
16/06/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
16/06/2021
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
12/04/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/04/2021
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
12/04/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
16/03/2021
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
28/02/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
30/01/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
13/01/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
13/01/2021
GPNX
NOTIFICATION PROCESSED BY IB
10/01/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
29/12/2020
PUBO
PUBLISHED FOR OPPOSITION
29/12/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
23/12/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
23/12/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/12/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/11/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/11/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/11/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/11/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/06/2020
GNRT
NON-FINAL ACTION E-MAILED
02/06/2020
CNRT
NON-FINAL ACTION WRITTEN
02/06/2020
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
01/05/2020
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
31/03/2020
ALIE
ASSIGNED TO LIE
19/03/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/03/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/03/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/03/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/03/2020
RFNT
REFUSAL PROCESSED BY IB
28/09/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/09/2019
RFRR
REFUSAL PROCESSED BY MPU
12/09/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/09/2019
CNRT
NON-FINAL ACTION WRITTEN
02/09/2019
MAFR
APPLICATION FILING RECEIPT MAILED
21/08/2019
DOCK
ASSIGNED TO EXAMINER
17/08/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/08/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/08/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GENETYPE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.